UPDATE : Friday, February 28, 2020
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan by Jeong Sae-im 2019-11-29 15:23
Hanmi's Chinese partner to start trials for anticancer treatment by Lee Han-soo 2019-11-28 17:38
GI Innovation licenses out immunotherapy drug candidate to Chinese firm by Lee Han-soo 2019-11-28 16:26
Takeda's ovarian cancer drug Zejula to get insurance benefit by Lee Han-soo 2019-11-28 15:36
ST Pharm submits IND application for colorectal cancer treatment in US by Lee Han-soo 2019-11-28 14:52
New Parkinson’s drug Ongentys lands on Korea by Jeong Sae-im 2019-11-28 14:52
Experts ascribe excessive diabetes hospitalization to lack of early treatment by Lee Han-soo 2019-11-28 11:26
Bristol-Myers Squibb Korea names new CEO by Lee Han-soo 2019-11-28 11:26
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
Daewoong ends P3 trial for drug treating gastroesophageal reflux disease by Lee Han-soo 2019-11-27 18:21
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics by Lee Han-soo 2019-11-26 18:48
Amgen releases analysis result showing benefits of LDL-C treatment by Lee Han-soo 2019-11-26 17:05
Roche’s flu treatment Xofluza wins approval by Kim Yun-mi 2019-11-26 16:08
Immunotherapies give hope for esophageal cancer patients by Kim Yun-mi 2019-11-26 15:37
GC Labcell hands over NK cell-treating tech to US lab by Lee Han-soo 2019-11-26 15:33
SK Biopharm to speed up global advance through XCOPRI’s launch by Lee Han-soo 2019-11-26 14:16
Huons Global wins KGMP certification for BTX plant by Lee Han-soo 2019-11-25 16:00
Gtree enrolls 200 patients for US trial of dry eye treatment by Lee Han-soo 2019-11-25 14:49
Daewoong renews EU GMP certification for BTX plant by Lee Han-soo 2019-11-25 11:55
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently by Lee Han-soo 2019-11-22 17:03
Back to Top